STAT

JULY 1, 2025

An experimental psychedelic therapy from the U.K. company Beckley Psytech significantly reduced symptoms of treatment-resistant depression in a mid-stage trial, newly released data show, raising expectations for a class of drugs racing toward potential approval by U.S. regulators.  Companies like Beckley, Atai Life Sciences, and Compass Pathways — the first two are in the process of merging — are now vying to bring psychedelic therapies to market at a time when the regulatory

Compounding 298

Compounding 298

PharmaVoice

JULY 1, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Drug Development 130

Drug Development 130

STAT

JULY 1, 2025

WASHINGTON — Health secretary Robert F. Kennedy Jr. has assembled a team that he says will work on ways to expand a federal program aimed at compensating people who have been injured by vaccines, though his power to make big changes without congressional action is unclear. “We just brought a guy in this week who is going to be revolutionizing the [National] Vaccine Injury Compensation program,” Kennedy said in an interview with Tucker Carlson posted Monday.

Vaccines 329

Vaccines 329

PharmaVoice

JULY 1, 2025

The AI revolution is driving tension between new technology and the traditional approaches in drugmaking. Biopharma leaders are trying to navigate those turbulent waters.

173

173

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

pharmaphorum

JULY 1, 2025

Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.

97

97

Beckers Hospital Review

JULY 1, 2025

A new national analysis offers a nuanced view of how healthcare access, affordability, treatment quality and hospital use intersect across the United States. The “ 2025 Scorecard on State Health System Performance ” from Commonwealth Fund evaluates all 50 states and the District of Columbia using 50 indicators spanning healthcare access and affordability, prevention and treatment, avoidable hospital use and costs, health outcomes, healthy behaviors, and equity.

Hospitals 105

Hospitals 105

Express Pharma

JULY 1, 2025

Cadila Pharmaceuticals has announced the launch of Bilacad Dex Syrup, to address the increasing burden of respiratory and allergy-related conditions with a novel fixed-dose combination of Bilastine, Dextromethorphan, and Phenylephrine. Bilacad Dex Syrup is a triple-action formula for comprehensive respiratory relief. It targets multiple symptoms associated with the common cold and allergic rhinitis, including cough, nasal congestion, and allergic manifestations such as sneezing and itching.

Dosage 75

Dosage Labelling 75

Pharma Times

JULY 1, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Moderna flu vaccine shows superior results in phase 3 study by John Pinching | 1st Jul 2025 | News Data shows mRNA-1010 could better protect adults aged 50 and above Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose licensed influenza vac

Vaccines 79

Vaccines Adverse Reactions 79

The Pharmacist

JULY 1, 2025

Changes will be made to the gateway points used under Pharmacy First in a move to make it easier for pharmacies to achieve the monthly payment for the scheme, Community Pharmacy England (CPE) has announced. Draft versions of revised Pharmacy First clinical pathways have been published on the NHS Business Services Authority (NHSBSA) website, showing […] The post Pharmacy First gateway changes to help increase payments appeared first on The Pharmacist.

Community Pharmacies 75

Community Pharmacies 75

Beckers Hospital Review

JULY 1, 2025

Health insurers covering more than 250 million Americans have unveiled a sweeping plan to streamline and reduce prior authorization requirements — a long-standing source of frustration and burnout for providers and patients. The voluntary reforms, hailed as a modernization effort by payers, aim to accelerate approvals, simplify processes and reduce administrative burdens across commercial, Medicare Advantage and managed Medicaid plans.

Insurance Coverage and Processing 94

Insurance Coverage and Processing Hospitals 94

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

JULY 1, 2025

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Good morning health tech readers! It may be a slow vacation week for some, but it’s a hot hot hot week so far for health tech policy news.

158

158

Express Pharma

JULY 1, 2025

Lupin announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Loteprednol Etabonate Ophthalmic Gel, 0.38 per cent. Loteprednol Etabonate Ophthalmic Gel, 0.38 per cent is bioequivalent to Lotemax SM Ophthalmic Gel of Bausch & Lomb. Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity.

63

63

The Pharmacist

JULY 1, 2025

New figures from the UK Health Security Agency (UKHSA) reveal a significant year-on-year rise in campylobacter and salmonella infections in England, prompting renewed warnings about food safety and hygiene. Campylobacter cases increased by 17.1% between 2023 and 2024, rising from 60,055 to 70,352 cases – the highest figure recorded in the past 10 years.

97

97

pharmaphorum

JULY 1, 2025

Beyond AI hype: How dynamic study forecasting is helping pharma gain control of clinical trial enrolment Nicole.

59

59

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Express Pharma

JULY 1, 2025

Rinri Therapeutics, a spinout company from the University of Sheffield dedicated to transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, has received approval to begin its first-in-human clinical trial. The UK’s Medicine and Healthcare products Regulatory Agency (MHRA) approved Rincell-1, a first-in-class otic neural progenitor cell therapy, for the first-in-human Phase I/IIa trial (1).

Labelling 68

Labelling 68

Beckers Hospital Review

JULY 1, 2025

As GLP-1 medications including Wegovy, Ozempic, Mounjaro and Zepbound reshape diabetes and weight loss care, recent developments such as new partnerships, safety questions and challenges in patient persistence show the landscape is quickly changing. Here are five recent GLP-1 developments: Novo Nordisk teams with WeightWatchers to simplify Wegovy access As of July 1, Novo Nordisk is partnering with WeightWatchers alongside Humana’s CenterWell Pharmacy to streamline the fulfillment and del

Diabetes 59

Diabetes Compounding Hospitals 59

The Pharmacist

JULY 1, 2025

Glenmark Pharmaceuticals Europe is recalling one batch of Omeprazole 20 mg/15 ml oral solution as a precautionary measure following a customer complaint indicating ‘precipitation and discoloration’ of the product in the bottles. The recall specifically affects batch number 3230528 (expiry date: 30/09/2025), distributed in packs of 14 bottles. The batch of medication, used to treat […] The post Customer complaint prompts recall of Omeprazole oral solution batch appeared first on The Pharmac

59

59

Beckers Hospital Review

JULY 1, 2025

Teva pharmaceuticals has issued a voluntary recall of one lot of its reflux medication after discovering that bottles contained tablets of a drug used to treat fluid retention. The recall affects lot No. 5420094 of 10 mg metoclopramide tablets in 100-count bottles after three sealed bottles were found to each contain a 20 mg torsemide tablet, a diuretic used to treat edema caused by heart, liver or kidney conditions, according to an FDA enforcement report issued June 20.

Hospitals 59

Hospitals 59

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmafile

JULY 1, 2025

Swedish biotech PharmNovo has submitted a clinical trial application (CTA) to the Spanish health authorities for its lead candidate PN6047, a new selective delta opioid receptor agonist. The appeal marks a significant milestone in the company’s mission to develop non-addictive alternatives for neuropathic pain. PN6047 is a small molecule that selectively targets the delta opioid […] The post PharmNovo submits CTA for non-addictive neuropathic pain therapeutic appeared first on Pharma

59

59

UWorld | RxPrep

JULY 1, 2025

class="skip-link screen-reader-text" href="#content" role="link" title="Skip to content"> Skip to content Search … Products Menu Toggle NAPLEX® Menu Toggle Online Course Course Book Test Bank MPJE® CPJE Product Features Menu Toggle Mobile App My Notebook Flashcards NAPLEX Sample Questions MPJE Sample Questions Our Difference Menu Toggle Why RxPrep Instructors Testimonials About Exams Menu Toggle NAPLEX Menu Toggle About NAPLEX Registration & Eligibility Exam Blueprint Scoring Guide S

Documentation 52

Documentation Patient Counseling Communication Inpatient 52

The Nontraditional Pharmacist

JULY 1, 2025

Chapters 00:00 Navigating Nontraditional Pharmacy Roles 02:54 Transitioning from Regulatory Affairs to Clinical Operations 05:45 Understanding Clinical Operations and Its Importance 08:54 The Role of Pharmacists in Clinical Trials 12:07 Career Pathways for Pharmacists in Clinical Operations 14:59 Networking and Mentorship in Nontraditional Pharmacy 17:53 Future Aspirations in the Pharmaceutical Industry Want to see Brendan’s Original Interview?

Hospitals 52

Hospitals Packaging Documentation Labelling 52

pharmaphorum

JULY 1, 2025

The proposed merger between Beckley Psytech and atai is unlocked as a psychedelic for depression hits all its endpoints in a phase 2b trial.

59

59

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Beckers Hospital Review

JULY 1, 2025

Rationalize your applications, they say. It will lead to cost savings, streamline your portfolio, and release resources for innovation and technological advancement, they say. So why do we groan at the idea of starting an application rationalization effort? Immediate reactions to AppRat, as it is commonly called, are often due to the complexity of the work and lack of employee bandwidth to do the work thoroughly.

Hospitals 59

Hospitals 59

The Pharmacist

JULY 1, 2025

Scotland’s community pharmacy sector is to receive a 4% uplift to support additional costs including National Insurance hikes, it has been revealed. Community Pharmacy Scotland (CPS) said it been informed by the Scottish Government that an uplift of ‘around £9.31m’ is to be applied to the global sum funding mechanism for community pharmacies for 2025/26. […] The post Scotland pharmacies to receive 4% global sum uplift appeared first on The Pharmacist.

Community Pharmacies 59

Community Pharmacies 59

PharmD Live

JULY 1, 2025

Introduction: Why Patient Consent Matters More Than Ever in RPM Remote Patient Monitoring (RPM) is revolutionizing chronic care management by improving patient outcomes and unlocking sustainable revenue streams for healthcare providers. But in 2025, RPM patient consent compliance is more than a billing formality; it is a legal, regulatory, and ethical imperative.

HIPAA 52

HIPAA Health and Personal Care Stores Documentation Hospitals 52

pharmaphorum

JULY 1, 2025

Skip to main content Tuesday 1 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Whi

Vaccines 66

Vaccines Diabetes Pharmaceutical Companies Pharmaceutical Companies 66

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Commerce

JULY 1, 2025

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how patient and caregiver insights shape drug development, regulatory decisions, and payer considerations in rare diseases.

Drug Development 52

Drug Development 52

pharmaphorum

JULY 1, 2025

Explore how North Carolina's Research Triangle is driving biotech innovation, attracting major pharma players, and strengthening local manufacturing—insights from BIO 2025 with Kyle Touchstone and Laura Rowley.

52

52

BioPharma Dive

JULY 1, 2025

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray into pivotal testing.

85

85

Beckers Hospital Review

JULY 1, 2025

Health systems across the U.S. are rapidly adopting AI to enhance patient care, streamline operations and reduce administrative burdens. From AI-powered documentation to using AI to to filter patient portal messages, health systems are finding innovative ways to integrate the technology into everyday workflows. Here’s a look at how seven health systems are leveraging AI to transform their operations, as reported by Becker’s since June 17.

Documentation 52

Documentation Hospitals 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management